Clinical Trial Update: A Study of Perjeta (Pertuzumab) in Combination With Herceptin (Trastuzumab) in Participants With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial results for Pertuzumab (Perjeta) in combination with Trastuzumab (Herceptin) in metastatic breast cancer, with results posted after study completi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Perjeta (pertuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-09-11